Predictive Value of Detectable Somatic Mutations By Next Generation Sequencing (NGS), at Day +100 (D100) Post-Allogeneic Hematopoietic Cell Transplantation (allo-HCT) on Survival Outcomes in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Somatic Mutations ◽

Hematopoietic Cell Transplantation ◽

Survival Outcomes ◽

Generation Sequencing ◽

Next-Generation Sequencing (NGS)-Based Clinical Testing is Recommended for the Detection of Gene Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia Predisposition Syndromes

Journal of Next Generation Sequencing & Applications ◽

10.4172/2469-9853.1000153 ◽

2017 ◽

Vol 04 (03) ◽

Author(s):

Ryan S Robetorye

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Gene Mutations ◽

Clinical Testing ◽

Next Generation ◽

Generation Sequencing ◽

Comparison of somatic mutations profiles from next-generation sequencing (NGS) of cell-free DNA (cfDNA) versus bone marrow (BM) in acute myeloid leukemia (AML).

10.1200/jco.2018.36.15_suppl.7051 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 7051-7051

Author(s):

Rita Elias Assi ◽

Maher Albitar ◽

Wanlong Ma ◽

Keyur Patel ◽

Koichi Takahashi ◽

...

Keyword(s):

Bone Marrow ◽

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Somatic Mutations ◽

Next Generation ◽

Free Dna ◽

Generation Sequencing ◽

Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia

American Journal of Clinical Pathology ◽

10.1093/ajcp/aqw016 ◽

2016 ◽

Vol 145 (4) ◽

pp. 497-506 ◽

Cited By ~ 19

Author(s):

Erica Reinig ◽

Fei Yang ◽

Elie Traer ◽

Ranjana Arora ◽

Shari Brown ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Chronic Myelomonocytic Leukemia ◽

Targeted Next Generation Sequencing ◽

Aids Diagnosis ◽

Myelomonocytic Leukemia ◽

Generation Sequencing ◽

Abstract 2299: Development of a novel next-generation sequencing (NGS)-based assay for measurable residual disease (MRD) inFLT3-ITD acute myeloid leukemia (AML) and its potential clinical application in patients

10.1158/1538-7445.am2019-2299 ◽

2019 ◽

Author(s):

Wenge Shi ◽

Christian Laing ◽

Wei Ding ◽

Marc Mycoco ◽

Jelveh Lameh ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Application ◽

Myeloid Leukemia ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Measurable Residual Disease ◽

Abstract 2299: Development of a novel next-generation sequencing (NGS)-based assay for measurable residual disease (MRD) inFLT3-ITD acute myeloid leukemia (AML) and its potential clinical application in patients

10.1158/1538-7445.sabcs18-2299 ◽

2019 ◽

Author(s):

Wenge Shi ◽

Christian Laing ◽

Wei Ding ◽

Marc Mycoco ◽

Jelveh Lameh ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Application ◽

Myeloid Leukemia ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Measurable Residual Disease ◽

Mutation analysis in 35 cases of newly diagnosed therapy-related acute myeloid leukemia (AML) by next-generation sequencing (NGS): A clinico-pathologic correlation.

10.1200/jco.2016.34.15_suppl.e18525 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e18525-e18525

Author(s):

Parsa Hodjat ◽

Kankana Ghosh ◽

Priyanka Priyanka ◽

Beenu Thakral ◽

Keyur Patel ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Mutation Analysis ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Next Generation ◽

Pathologic Correlation ◽

Generation Sequencing ◽

Poster: AML-319: Next-Generation Sequencing (NGS) Panel Fails to Predict Overall Survival (OS) and Disease-Free Survival (DFS) in a Cohort of Peruvian Patients with Acute Myeloid Leukemia (AML)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01365-3 ◽

2021 ◽

Vol 21 ◽

pp. S217

Author(s):

Antonio Carrasco-Yalán ◽

Tatiana Saldarriaga-Valiente ◽

Jorge Valdés Gómez ◽

John Pando-Mayta ◽

Franco Doimi ◽

...

Keyword(s):

Overall Survival ◽

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Disease Free Survival ◽

Free Survival ◽

Disease Free ◽

Generation Sequencing ◽

Abstract 01: Development of a targeted panel for acute myeloid leukemia (AML) by using next-generation sequencing (NGS)

10.1158/1557-3265.pmsclingen15-01 ◽

2016 ◽

Author(s):

Anup Tilak ◽

Ramakrishna Sompallae ◽

Aaron Stence ◽

Natalya Guseva ◽

Aaron Bossler

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Next Generation ◽

Generation Sequencing ◽

Identification of additional therapeutic options for de novo acute myeloid leukemia (AML) patient enabled by next generation sequencing (NGS).

10.1200/jco.2015.33.15_suppl.e18027 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e18027-e18027

Author(s):

Jason G Harb ◽

Amber N Essenmacher ◽

Karen-Sue Carlson ◽

Matthew W Anderson ◽

Durga P. Dash

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

De Novo ◽

Therapeutic Options ◽

Next Generation ◽

Generation Sequencing ◽

Impact of next-generation sequencing (NGS) on treatment selection in acute myeloid leukemia (AML).

10.1200/jco.2018.36.15_suppl.103 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 103-103

Author(s):

Rita Elias Assi ◽

Ana Alfonso Pierola ◽

Devendra KC ◽

Yasmin Mohammed Abaza ◽

Abdallah Abou Zahr ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Treatment Selection ◽

Next Generation ◽

Generation Sequencing ◽